Dr. Edwin Moses is a Chief Executive Officer & Executive Director at Ablynx NV.
He is on the Board of Directors at Ablynx NV. Dr. Moses was previously employed as a Chairman by Capricorn Venture Partners NV, a Non-Executive Director by Fusion IP Plc, an Executive Chairman by Pharmaceutical Profiles Group Ltd., a Chairman by Paradigm Therapeutics Ltd., a Chairman by Inpharmatica Ltd., a Chairman by Oxford Asymmetry International Plc, a Principal by Amersham International Plc, a Chairman by BioImage A/S, a Non-Executive Chairman by ClinPhone Ltd., a Chairman by ClinPhone Plc, a Non-Executive Chairman by Lectus Therapeutics Ltd., a Non-Executive Chairman by Phoqus Pharmaceuticals Plc, and a Chairman by Proimmune Ltd.
He also served on the board at Capricorn Health-Tech Fund NV, The London Technology Network, Inhibox Ltd., Imaging Research Solutions Ltd., AMS Biotechnology Ltd., Avantium Technologies BV, European Biopharmaceutical Enterprises, Evotec AG, Ionix Pharmaceuticals Ltd., Prolysis Ltd. and ProPharma Ltd.
He received his undergraduate degree from The University of Sheffield and a doctorate degree from The University of Sheffield.